Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Now, Scripps Research scientists have uncovered new structures of transthyretin. Their findings, published in Nature Structural & Molecular Biology on January 22, 2025, show how the three-dimension ...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration ...

In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

but other amyloid diseases as well," says Lander. In addition to Lander, Kelly, and Basanta, authors of the study, "The conformational landscape of human transthyretin revealed by cryo-EM," are ...

The FDA has granted medical manufacturer Beckman Coulter a Breakthrough Device Designation for its new plasma ratio, a blood ...